Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Stocks Trader Talk -- Ignore unavailable to you. Want to Upgrade?

To: NCKEV who wrote (457)	3/7/2002 9:32:25 AM
From: Wowzer	Respond to of 787

Don't worry, I will be out soon! :-). Playing for lunch money. edit I am out at 21....

To: NCKEV who wrote (457)	3/7/2002 10:00:07 AM
From: Joe Stocks	Respond to of 787

Biotech's. I could see doing intraday tades or daytrades but the risk/reward is not there for me. Scape, you say a "good trade". I don't see how a company that is losing money - I think $4 plus this year- is worth a trade long when there are so many more stocks out there that have valuations that you can grasp. No one has been able to explain to me the pricing of huge money losing biotech's relative to what ever they have in the pipeline. It appears to me the bigger the cure they are chasing the bigger the valuation. Stocks prices seem to reflect the "bigger fool theory" in that pricing is based on what someone will pay for it based on pipedreams. Anyway SEPR is down to less than $18 as I type. Scape, tell me why GNTA is worth what it is selling for. Joe